Home » Topics » BioWorld

BioWorld
RSS

CATVAX MOVING INTO THE CLINIC

April 10, 1992

ROBERTS ACQUIRES RIGHTS TO TWO DRUGS

April 10, 1992

GLIATECH FILES INITIAL PUBLIC OFFERING

April 10, 1992

PRELIMINARY DATA ON HEPATITIS B THERAPY

April 10, 1992

FUTURE MEDICAL ACQUIRES MAB TECHNOLOGY

April 10, 1992

NPS RAISES $5 MILLION IN VENTURE ROUND

April 10, 1992

INCYTE SEPSIS TEST CHALLENGES CENTOXIN

April 10, 1992

NEW VERSION OF HEPARIN IS MORE EFFECTIVE

April 9, 1992

HYPERTENSION GENE REJECTED IN NEW JOURNAL

April 9, 1992

AUSTRIA FIRST TO APPROVE ddC

April 9, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...